These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 19426877)

  • 1. Generation of mtDNA-exchanged cybrids for determination of the effects of mtDNA mutations on tumor phenotypes.
    Ishikawa K; Hayashi J
    Methods Enzymol; 2009; 457():335-46. PubMed ID: 19426877
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reversible regulation of metastasis by ROS-generating mtDNA mutations.
    Ishikawa K; Koshikawa N; Takenaga K; Nakada K; Hayashi J
    Mitochondrion; 2008 Sep; 8(4):339-44. PubMed ID: 18727959
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of mutant mitochondrial DNA harboring the MELAS A3243G mutation in human cybrid cells after cell-cell fusion with normal tissue-derived fibroblast cells.
    Yano T; Tanaka M; Fukuda N; Ueda T; Nagase H
    Int J Mol Med; 2010 Jan; 25(1):153-8. PubMed ID: 19956914
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced glycolysis induced by mtDNA mutations does not regulate metastasis.
    Ishikawa K; Hashizume O; Koshikawa N; Fukuda S; Nakada K; Takenaga K; Hayashi J
    FEBS Lett; 2008 Oct; 582(23-24):3525-30. PubMed ID: 18805414
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel function of mtDNA: its involvement in metastasis.
    Ishikawa K; Hayashi J
    Ann N Y Acad Sci; 2010 Jul; 1201():40-3. PubMed ID: 20649537
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nuclear DNA but not mtDNA controls tumor phenotypes in mouse cells.
    Akimoto M; Niikura M; Ichikawa M; Yonekawa H; Nakada K; Honma Y; Hayashi J
    Biochem Biophys Res Commun; 2005 Feb; 327(4):1028-35. PubMed ID: 15652499
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contribution of somatic mutations in the mitochondrial genome to the development of cancer and tolerance against anticancer drugs.
    Ohta S
    Oncogene; 2006 Aug; 25(34):4768-76. PubMed ID: 16892089
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cybrid models of mtDNA disease and transmission, from cells to mice.
    Trounce IA; Pinkert CA
    Curr Top Dev Biol; 2007; 77():157-83. PubMed ID: 17222703
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The A8296G mtDNA mutation associated with several mitochondrial diseases does not cause mitochondrial dysfunction in cybrid cell lines.
    Bornstein B; Mas JA; Fernández-Moreno MA; Campos Y; Martín MA; del Hoyo P; Rubio JC; Arenas J; Garesse R
    Hum Mutat; 2002 Mar; 19(3):234-9. PubMed ID: 11857739
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mitochondria in cybrids containing mtDNA from persons with mitochondriopathies.
    Swerdlow RH
    J Neurosci Res; 2007 Nov; 85(15):3416-28. PubMed ID: 17243174
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced generation of mitochondrial reactive oxygen species in cybrids containing 4977-bp mitochondrial DNA deletion.
    Jou MJ; Peng TI; Wu HY; Wei YH
    Ann N Y Acad Sci; 2005 May; 1042():221-8. PubMed ID: 15965066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced ROS production and antioxidant defenses in cybrids harbouring mutations in mtDNA.
    Vives-Bauza C; Gonzalo R; Manfredi G; Garcia-Arumi E; Andreu AL
    Neurosci Lett; 2006 Jan; 391(3):136-41. PubMed ID: 16165271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of cybrid cell lines containing mtDNA from Huntington's disease patients.
    Swerdlow RH; Parks JK; Cassarino DS; Shilling AT; Bennett JP; Harrison MB; Parker WD
    Biochem Biophys Res Commun; 1999 Aug; 261(3):701-4. PubMed ID: 10441489
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The genetics of the mitochondrial DNA of mammalian somatic cells, their hybrids and cybrids.
    Coon HG
    Natl Cancer Inst Monogr; 1978 May; (48):45-55. PubMed ID: 372818
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distinct nuclear gene expression profiles in cells with mtDNA depletion and homoplasmic A3243G mutation.
    Jahangir Tafrechi RS; Svensson PJ; Janssen GM; Szuhai K; Maassen JA; Raap AK
    Mutat Res; 2005 Oct; 578(1-2):43-52. PubMed ID: 16202796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ROS-generating mitochondrial DNA mutations can regulate tumor cell metastasis.
    Ishikawa K; Takenaga K; Akimoto M; Koshikawa N; Yamaguchi A; Imanishi H; Nakada K; Honma Y; Hayashi J
    Science; 2008 May; 320(5876):661-4. PubMed ID: 18388260
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of normal human fibroblast mitochondrial DNA on segregation of HeLaTG Mitochondrial DNA and on tumorigenicity of HeLaTG cells.
    Hayashi J; Werbin H; Shay JW
    Cancer Res; 1986 Aug; 46(8):4001-6. PubMed ID: 3731069
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mitochondrial DNA mutations in human cancer.
    Chatterjee A; Mambo E; Sidransky D
    Oncogene; 2006 Aug; 25(34):4663-74. PubMed ID: 16892080
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polymorphic mutations in mouse mitochondrial DNA regulate a tumor phenotype.
    Takibuchi G; Imanishi H; Morimoto M; Ishikawa K; Nakada K; Toyama-Sorimachi N; Kikkawa Y; Takenaga K; Hayashi J
    Mitochondrion; 2013 Nov; 13(6):881-7. PubMed ID: 23932994
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Specific mtDNA mutations in mouse carcinoma cells suppress their tumor formation via activation of the host innate immune system.
    Imanishi H; Takibuchi G; Kobayashi T; Ishikawa K; Nakada K; Mori M; Kikkawa Y; Takenaga K; Toyama-Sorimachi N; Hayashi J
    PLoS One; 2013; 8(9):e75981. PubMed ID: 24098752
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.